News
on
Credit:
Courtesy of NIH Medical Arts
|
News Release
Targeting cell’s ‘trash compactor’ could lead to new antiviral strategy to fight COVID-19 Researchers at the National Institutes of Health have discovered a biological pathway that the novel coronavirus appears to use to hijack and exit cells as it spreads through the body. A better understanding of this important pathway may provide vital insight...
|
Research Feature
Peter Libby, M.D., never imagined nearly 40 years ago that his research would contribute to the current understanding of how the novel coronavirus targets and ravages the blood vessels in people with COVID-19. In the 1980s, Libby, then an assistant professor of medicine at Tufts University School of Medicine, was the first to discover that arterial...
|
Research Feature
Could bring improved diagnostics and treatments for dementia, stroke, brain trauma, and more The blood-brain barrier has been called one of neurology’s greatest challenges. The thin, selectively permeable membrane acts almost like plastic wrap, protecting the brain tissue from dangerous pathogens and toxins in the blood. In short, it maintains the...
|
Research Feature
Not so long ago, when doctors saw a patient with the inflammatory skin condition psoriasis, their first line of attack was to address the signs they could see—red, itchy, scaly patches, mostly on the knees, elbows, trunk and scalp. But research over the last several years is forcing a rethinking of the very nature of this common disease. Rather...
|
News Release
The National Institutes of Health has launched two of three adaptive Phase 3 clinical trials evaluating the safety and effectiveness of varying types of blood thinners to treat adults diagnosed with COVID-19. Part of the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) initiative, these trials will be conducted at more than 100...
|
News Release
The trend could threaten decades of public health work against heart disease After nearly 15 years on an upward trend, awareness among Americans about high blood pressure and how to control and treat it is now on the decline, according to a new study. Even with the help of blood pressure medications, some groups, including older adults, are less...
|
News Release
Smoking cessation could be a path to fewer strokes, researchers say African Americans who smoke are nearly 2.5 times more likely to have a stroke than those who never smoked, while former smokers show a similarly lower risk as never smokers, according to a new study funded by the National Institutes of Health. The findings from the Jackson Heart...
|
Research Feature
Two doctors point the way to better heart health for midlife black women Spend a little time with Marilyn Gaston, M.D., and Gayle Porter, Psy.D., and it’s not hard to guess they’ve been pals for a long time—42 years to be exact. They finish each other’s sentences, can tell you everything about the other’s family and friends. They even live together...
|
Research Features
Chris Camp recalls the early days of the HIV/AIDS epidemic, when being diagnosed as HIV positive was considered a virtual death sentence. Doctors had no medications that could really help. People with the disease often did not survive more than a year or two. Camp, now 63, says he personally lost more than 500 friends. Among them: his first husband...
|
Media Availability
WHAT: The National Institutes of Health have announced five new contract awards for the next phase of the Jackson Heart Study (JHS), the largest research study in history to investigate the biological, , and environmental risk factors associated with the...
|
News Release
A sickle cell anemia study has found that the drug hydroxyurea is as effective as blood transfusions in children to reduce blood flow velocities in the brain, which is a key risk factor for stroke. The findings appear in The Lancet and were presented at the annual meeting of the American Society of Hematology. Some children living with sickle cell...
|
News Release
Researchers have begun enrolling participants in a multicenter international clinical trial to test whether statin administration can reduce the risk for major adverse cardiovascular events, such as heart attacks, strokes, and heart disease, in people with HIV infection. The trial is supported by the National Institutes of Health’s National Heart...
|
News Release